Class III
Terminated
Options Rx Anti-Oxidant Oil-Free Sunscreeen (Octinoxate 7.5%, Octisalate 5%, Oxybenzone 6%), 4.5 oz./128 g tube, Mfg. For Credentials Skincare Fort Worth, TX 76155
This recall has been terminated (originally issued December 26, 2018).
- Company
- Cbi Laboratories, Inc.
- Recall Initiated
- December 10, 2018
- Posted
- December 26, 2018
- Recall Number
- D-0342-2019
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 2055 tubes
- Firm Location
- Fort Worth, TX, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.
Distribution
United States, Maldives, Canada, United Arab Emirates, and New Zealand
Lot / Code Info
Lot #: 129114 Exp. 06/2019; 131927,133239 Exp. 03/2020; 126292, Exp.01/2019.
Other recent Class III Drug recalls
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Via...
Slate Run Pharmaceuticals
· Mar 4, 2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceutica...
Unichem Pharmaceuticals Usa Inc.
· Feb 18, 2026
parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL),...
Haleon Us Holdings Llc
· Feb 4, 2026
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceutic...
Novadoz Pharmaceuticals Llc
· Feb 4, 2026
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd.,...
Cipla Usa, Inc.
· Jan 28, 2026